ERBB2 in Pediatric Cancer: Innocent Until Proven Guilty
Open Access
- 1 August 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 10 (7) , 508-517
- https://doi.org/10.1634/theoncologist.10-7-508
Abstract
Adult oncologists and their research colleagues have “led the charge” in the war on cancer. Their efforts have generated effective new chemotherapies that target cancer causing molecular alterations....Keywords
Funding Information
- NIH (CA96832-01, CA21765, CA0114937-01)
- V-Foundation for Cancer Research
- Sontag Foundation's
- American Lebanese Syrian Associated Charities
This publication has 97 references indexed in Scilit:
- Cancer genes and the pathways they controlNature Medicine, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- The ErbB receptors and their role in cancer progressionExperimental Cell Research, 2003
- HER4 Mediates Ligand-Dependent Antiproliferative and Differentiation Responses in Human Breast Cancer CellsMolecular and Cellular Biology, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancerThe EMBO Journal, 2000
- The Hallmarks of CancerCell, 2000
- ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signalingThe EMBO Journal, 1997
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987